Owens & Minor, Inc. (NYSE:OMI) Shares Purchased by Algert Global LLC

Algert Global LLC boosted its holdings in shares of Owens & Minor, Inc. (NYSE:OMI) by 189.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 276,438 shares of the company’s stock after purchasing an additional 180,922 shares during the quarter. Algert Global LLC’s holdings in Owens & Minor were worth $4,337,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in OMI. Quarry LP increased its stake in shares of Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after buying an additional 1,561 shares during the last quarter. Innealta Capital LLC acquired a new position in Owens & Minor during the 2nd quarter worth $43,000. DekaBank Deutsche Girozentrale increased its position in shares of Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $43,000 after purchasing an additional 1,356 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after purchasing an additional 1,780 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Owens & Minor by 100.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company’s stock worth $82,000 after purchasing an additional 3,044 shares during the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Trading Up 1.0 %

Shares of OMI opened at $12.35 on Monday. The firm has a fifty day moving average of $13.75 and a 200-day moving average of $15.16. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor, Inc. has a 1 year low of $11.42 and a 1 year high of $28.35.

Owens & Minor (NYSE:OMI) last posted its earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same period in the previous year, the business posted $0.44 EPS. Owens & Minor’s revenue was up 5.0% on a year-over-year basis. Equities analysts forecast that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. JPMorgan Chase & Co. lowered their price objective on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a report on Wednesday, August 21st. UBS Group lowered their price target on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, November 5th. StockNews.com cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Citigroup lowered their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research note on Tuesday, November 5th. Finally, Robert W. Baird dropped their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $18.50.

Owens & Minor Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.